Technology News

Emergent BioSolutions Launches Anthrax Disease Website

Monday, May 11, 2009 5:02:00 AM PDT | VentureDeal Staff

Rockville, Maryland  --  Biotechnology company Emergent BioSolutions (NYSE: EBS) announced the launch of a new website to provide education about anthrax disease and the company's anthrax vaccine.

Called and named after the company's vaccine product, the website educates visitors about the published data and updated information on the five dose schedule of administration.

“Information about recent product enhancements such as the five-dose schedule and intramuscular route of administration is made readily available on,” said Dr. James Jackson, chief scientific officer of Emergent BioSolutions. “Emergent has developed this website to provide information about the threat of anthrax and to help individuals make informed decisions. BioThrax, the only FDA-licensed anthrax vaccine, is commercially available in the United States and in certain international markets. provides a portal of information about the risk of infection and about protection through prevention,” he added.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1